Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499967 · ClinicalTrials.gov registry record · Phase 1
Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
A Phase 1 study, sponsored by Gilead Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 202
- Enrollment target
NCT00499967: Completed Phase 1 study, sponsored by Gilead Sciences.
NCT00499967 is a Phase 1 study that has completed, run by Gilead Sciences. The registered enrollment target is 202 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (237% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499967, a Phase 1 study, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 202 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety, tolerability and activity of GS-9191 ointment in the treatment of genital warts. GS-9191 ointment is intended for topical application directly to genital warts on the skin.
Interventions
- DRUG Placebo
- DRUG GS-9191 ointment
- DRUG GS-9191
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
What the finished NCT00499967 record still lists
NCT00499967 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (237% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00499967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00499967 about?
NCT00499967 is a clinical study titled "Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts". The purpose of this study is to assess the safety, tolerability and activity of GS-9191 ointment in the treatment of genital warts. GS-9191 ointment is intended for topical application directly to genital warts on the skin.
What is the current status of trial NCT00499967?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 202 participants. The study started on 2007-08. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00499967?
The interventions under investigation include: Placebo (DRUG), GS-9191 ointment (DRUG), GS-9191 (DRUG).
Who is sponsoring clinical trial NCT00499967?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00499967's enrollment target sits among peer trials
202 258th of 2000 higher than 1,743 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia